CoreCap Advisors »

C4 Therapeutics shares owned by CoreCap Advisors

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $362 227 1.60
2024-12-31 $461 128 3.60

More positions owned by CoreCap Advisors

State Street Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard S&p 500 Etf Etf (VOO)
State Street Technology Select Sector Spdr Etf Etf (XLK)
Invesco Qqq Trust Series I Etf (QQQ)
State Street Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Schwab U.s. Small-cap Etf Etf (SCHA)
Goldman Sachs Marketbeta U.s. Equity Etf Etf (GSUS)
Ishares Core S&p 500 Etf Etf (IVV)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Growth Etf Etf (VUG)

View all positions for CoreCap Advisors

Top funds holding C4 Therapeutics

Lynx1 Capital Management
Soleus Capital Management
OrbiMed Advisors
Daniel D. Thurber
Vanguard Group
Millennium Management
Silverarc Capital Management
BlackRock
Bain Capital Life Sciences Investors
Renaissance Technologies
Tang Capital Management
Two Sigma Investments
Two Sigma Advisers
Geode Capital Management
Susquehanna International

View all funds holding C4 Therapeutics